Tridegin

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameTridegin

Drug Alias NameN/A

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionTransglutaminases inhibitors

TargetsTransglutaminases

Therapy Area/IndicationsThrombosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBiopharm (UK) Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBiopharm (UK) Ltd

Active IndicationsN/A

Inactive IndicationsThrombosis

Other Information

ATC CodeN/A

Related LinksN/A